QuickView for CXPTA (compound)

1. Cardiac gene expression regulated by single fatty acids in wildtype and PPARa null mice
2. Hepatocytes treated with non-genotoxic carcinogens
3. HepG2 cells treated with genotoxic and non-genotoxic agents
4. Livers of CD-1 mice treated with genotoxic, non-genotoxic or non-hepatocarcinogens
5. Primary hepatocytes treated with non-genotoxic carcinogens or non-carcinogens

1. Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator.
2. A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular …
3. Enantiomer separation and indirect chromatographic absolute configuration prediction of chiral pirin…
4. Interference of alpha-alkyl-substituted pirinixic acid derivatives with neutrophil functions and sig…
5. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.

There were no clinical trials for CXPTA